The Challenges of Novel Therapies in the Care of the Critically Ill Cancer Patient

The rapid development of novel therapies which simultaneously offer hope in the most challenging cases but which often come with a raft of potential toxicities, some of which we are yet to fully elucidate, presents a new frontier in critical care. This chapter summarizes the current state of the art in the intensive care management of patients who have been treated with targeted therapies that modulate the immune system and discusses the implications for the development of support systems in the future.